Professional Summary
Professional Overview
Ted Suh is the Vice President of Chemistry at Orionis Biosciences, a leading pharmaceutical company based in Boston, Massachusetts. With over 25 years of extensive experience in the biotech and pharmaceutical industries, Suh is a seasoned leader with a proven track record in strategic planning, operations, and drug discovery.
Experience Summary
Current Role
As the Vice President of Chemistry at Orionis Biosciences, Suh oversees all chemistry-related activities, including lead optimization, compound screening, and analogue synthesis. Under his leadership, the chemistry team has successfully advanced multiple drug candidates through preclinical development, with two compounds currently in Phase I clinical trials. Suh's strategic vision and technical expertise have been instrumental in driving the company's innovative pipeline and strengthening its position as a leader in the field of small molecule therapeutics.
Career Progression
Prior to joining Orionis Biosciences, Suh held various senior-level positions at leading pharmaceutical and biotech companies, including Biovica International AB, Eisai US, and GlaxoWellcome. As the Senior Director of US Business Development at Biovica, he played a pivotal role in expanding the company's presence in the North American market and securing strategic partnerships. At Eisai US, he served in roles of increasing responsibility, including Senior Director of Strategic Planning and Operations for the Biomarkers and Personalized Medicine division, and Senior Director and Deputy President of the Lead Discovery department. Suh's extensive experience in drug discovery, business development, and strategic planning has been instrumental in shaping his career trajectory and enabling him to make significant contributions to the industry.
Academic Background
Suh holds a Ph.D. in Organic Chemistry from the University of California, Berkeley, where he specialized in the development of novel synthetic methodologies and the total synthesis of complex natural products. His academic achievements have been recognized through numerous awards and publications in peer-reviewed journals.
Areas of Expertise
- Small molecule drug discovery
- Medicinal chemistry and lead optimization
- Compound screening and analogue synthesis
- Strategic planning and operations management
- Business development and partnership negotiations
- Biomarker and personalized medicine strategies
Professional Impact
During his tenure at Eisai US, Suh played a key role in the successful development and commercialization of several blockbuster drugs, contributing to the company's growth and revenue generation. At Orionis Biosciences, he has been instrumental in advancing the company's pipeline, with two drug candidates currently in Phase I clinical trials. Suh's technical expertise, strategic vision, and collaborative leadership style have been invaluable in driving innovation and delivering tangible results for the organizations he has served.
Conclusion
With his extensive industry experience, technical prowess, and proven track record of success, Ted Suh is a highly respected leader in the pharmaceutical and biotech sectors. As the Vice President of Chemistry at Orionis Biosciences, he continues to leverage his expertise to advance the company's innovative pipeline and solidify its position as a leader in the development of novel small molecule therapeutics.
